secwatch.observer — SEC 8-K summary
======================================

Issuer:     MANGOCEUTICALS, INC. (MGRX)
CIK:        0001938046
Form:       8-K
Filed at:   2025-01-21T23:59:59+00:00
Accession:  0001493152-25-003054
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 5.02, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mangoceuticals converts $150K note into 100K shares; appoints Antonios Isaac as President & Director
--------------------------------------------------------------------------------

- Debt conversion with Mill End Capital: $150K promissory note converted to 100K restricted common shares at $1.50/share.
- Antonios Isaac appointed as Director and President; enters 12-month consulting agreement at $10K/month.
- Final 250 shares of Series B Preferred Stock sold for $250K, completing Fourth Closing under 2024 SPA.
- Conversion of note triggers anti-dilution repricing: all outstanding warrants and Series B conversion price adjusted to $1.50/share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1938046/000149315225003054/0001493152-25-003054-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1938046/000149315225003054/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-003054

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer